International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

Young Scientist Awards

Presented for Best Young Scientist Oral and Best Young Scientist Poster Presentations

The awards shall be presented for the best Young Scientist oral and best Young Scientist poster presentations at the IATDMCT Congress.

  • One award will be presented for the best Young Scientist oral presentation.
  • One award will be presented for the best Young Scientist poster presentation.

Terms of Reference

  • The Young Scientist (YS) awards will be presented by the President at the Closing Ceremony of each Congress.
  • The two winners will be awarded the sum of $ 750 each.
  • These prizes are reserved, according to the regulations of the Young Scientists Committee (YSC), to IATDMCT members aged 40 years or younger.
  • The YS member must be the first author of the oral / poster presentation abstract.
  • The YS member will have to be registered and present at the Congress.
  • The YS member will have to apply for the awards when submitting the abstract.
  • Members of the YSC are not eligible to be considered for the awards.
  • The jury will be made up of at least three members of the YSC.
  • If a member of the YSC is a co-author of the abstract, it will be considered for the award, however, the YSC co-author will be excluded from assessing this entry.
  • In case of equal top marks for a given award, the jury will deliberate and then a vote will be held to select the recipient of the award by "simple majority".
  • The same person should not receive both of these awards, unless duly justified by exceptional achievements in the jury’s opinion.
  • If, in the opinion of the Young Scientist Committee, no suitable candidate is available the Awards shall not be presented.

Pre-Congress Abstract Evaluation Guidelines

  • Prior to the Congress the YSC will select, from the submitted abstracts, a minimum of 20 Oral abstracts and a minimum of 20 Poster abstracts to be assessed for the awards at the Congress.
  • Each abstract will be evaluated by 3 members of the YSC.
  • The abstracts will be assessed based on the following criteria:
    • Clarity
      (Mark 1 to 2, with 1 being the highest)
    • Significance / impact in TDM or CT
      (Mark 1 to 3, with 1 being the highest)
    • Scientific content / Technical challenge
      (Mark 1 to 5, with 1 being the highest)
    • Scientific novelty
      (Mark 1 to 2, with 1 being the highest)

Congress Awards Evaluation Guidelines

Following the pre-Congress evaluation the selected oral and poster presentations will be assessed by 3 members of the YSC jury independently during the Congress. The Oral and Poster presentation will be assessed based on the following criteria:

  • Originality, scientific or clinical importance
    (Mark 1 to 5, with 1 being the highest)
  • Degree of scientific/technical content and challenge
    (Mark 1 to 5, with 1 being the highest)
  • Knowledge of subject area and ability to respond to questions
    (Mark 1 to 5, with 1 being the highest)
  • Quality of the poster, its structure and visual presentation
    or
    Quality of slides, its structure and delivery of oral presentation
    (Mark 1 to 5, with 1 being the highest)

2015 Recipient - Best Oral Presentation

Thomas 150x200
Fabienne Thomas, France

Sponsored by

IATDMCT


IATDMCT Logo Blue 150x150

Lethal toxicity of 5-fluorouracil in the era of personalized therapy: discovery of a novel mutation disrupting the dihydropyrimidine deshydrogenase activity.
Thomas F1, Hennebelle I, Marsili S, Dhelens C, Garnier-Tixidre C, Bonadona A, Penel N, Goncalves A, Delord JP, Toulas C, Chatelut E
1Institut Universitaire du Cancer Toulouse, France

Past Recipients

  • 2013 Jessica Welter, Germany
  • 2011 Andrea E Schwaninger, Germany
  • 2009 Flora Musuamba Tshinanu, Belgium

2015 Recipient - Best Poster

Pouche 150x200
Lucie Pouche, France

Sponsored by

IATDMCT


IATDMCT Logo Blue 150x150

Preliminary results on the pharmacoepigenetics of calcineurin inhibitors using an in-vitro model: pitfalls and perspectives
Pouche L1, Lebreton V, Gonzalez J, Marquet P, Picard N
1 University Hospital of Limoges, France

Past Recipients

  • 2013 Violetter MG Gijsen, Netherlands/Canada
  • 2011 Fabien Lamoureux, France
  • 2009 Isabelle Delattre

contactus273x169

Contact Us
IATDMCT Awards
Young Scientist Committee